Primary Myelofibrosis Recruiting Phase 2 Trials for Cefotaxime (DB00493)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

DBCOND0001581 (Primary Myelofibrosis)Recruiting2 IdentifierTitlePurposeDrugs
NCT03303950Busulfan, Fludarabine, Donor Stem Cell Transplant, and Cyclophosphamide in Treating Patients With Multiple Myeloma or MyelofibrosisTreatment
NCT02251821JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary MyelofibrosisTreatment